Taking into account the correlations between angiogenin protein and copper in physiological and pathological conditions of the brain, a promising pharmacological approach in brain tumours therapy is the use of ANG as molecular target, whose activity may be modulated by the presence of copper ions. The gene discussed is ANG; the disease is brain neoplasm.